Adamek RJ et al. |
Primary and acquired Helicobacter pylori resistance to clarithromycin, metronidazole, and amoxicillin--influence on treatment outcome. |
1998 |
Am. J. Gastroenterol. |
pmid:9517645
|
Bardhan KD et al. |
Ranitidine bismuth citrate with clarithromycin given twice daily effectively eradicates Helicobacter pylori and heals duodenal ulcers. |
1998 |
Am. J. Gastroenterol. |
pmid:9517644
|
Williamson R et al. |
New options in Helicobacter pylori eradication: efficacy, resistance and synergy. |
1998 |
Scand. J. Gastroenterol. Suppl. |
pmid:9515751
|
Moayyedi P |
Amoxycillin dual therapy against Helicobacter pylori--the final nail in the coffin? |
1997 |
Ital J Gastroenterol Hepatol |
pmid:9513823
|
Sato K et al. |
Antimicrobial activities of benzoxazinorifamycin KRM-1648, clarithromycin and levofloxacin against intracellular Mycobacterium avium complex phagocytosed by murine peritoneal macrophages. |
1998 |
J. Antimicrob. Chemother. |
pmid:9511040
|
Carlson LD et al. |
Standardized BACTEC method to measure clarithromycin susceptibility of Mycobacterium genavense. |
1998 |
J. Clin. Microbiol. |
pmid:9508306
|
Rosina P et al. |
Fixed drug eruption from clarithromycin. |
1998 |
Contact Derm. |
pmid:9506224
|
Ziering W and McElvaine P |
Randomized comparison of once-daily ceftibuten and twice-daily clarithromycin in the treatment of acute exacerbation of chronic bronchitis. |
1998 Jan-Feb |
Infection |
pmid:9505188
|
Hocqueloux L et al. |
Pulmonary Mycobacterium avium complex disease without dissemination in HIV-infected patients. |
1998 |
Chest |
pmid:9498982
|
Dubois A et al. |
Cure of Helicobacter pylori infection by omeprazole-clarithromycin-based therapy in non-human primates. |
1998 |
J. Gastroenterol. |
pmid:9497216
|
Kusuhara H et al. |
Evaluation of combined antibiotic-omeprazole therapies in Helicobacter pylori-infected Mongolian gerbils. |
1998 |
J. Gastroenterol. |
pmid:9497215
|
Payen MC et al. |
[Manifestations, diagnosis and treatment of non-tuberculous mycobacterial infections in patients with HIV infection]. |
1997 |
Rev Mal Respir |
pmid:9496599
|
Pérez Mota A et al. |
Helicobacter pylori, efficacy of the new triple therapy in six and twelve-day schedules. |
1997 |
Rev Esp Enferm Dig |
pmid:9494375
|
Boixeda de Miquel D |
[Efficacy of the triple therapy in the eradication of H. pylori in peptic ulcer]. |
1997 |
Rev Esp Enferm Dig |
pmid:9494374
|
Kondoh K and Hashiba M |
[Inhibitory effect of macrolide antibiotics on biofilm formation by Pseudomonas aeruginosa]. |
1998 |
Nippon Jibiinkoka Gakkai Kaiho |
pmid:9493436
|
Hermon-Taylor J et al. |
Mycobacterium paratuberculosis cervical lymphadenitis, followed five years later by terminal ileitis similar to Crohn's disease. |
1998 |
BMJ |
pmid:9492675
|
Igea JM and Lázaro M |
Hypersensitivity reaction to clarithromycin. |
1998 |
Allergy |
pmid:9491242
|
Ridgway GL et al. |
The in-vitro activity of grepafloxacin against Chlamydia spp., Mycoplasma spp., Ureaplasma urealyticum and Legionella spp. |
1997 |
J. Antimicrob. Chemother. |
pmid:9484871
|
Hotz J |
[Reflux disease of the gastrointestinal tract. Acute therapy and long-term care in daily practice. 2. Therapeutic procedure--diagnosis--therapy-diagram]. |
1997 |
Fortschr. Med. |
pmid:9480263
|
Cammarota G et al. |
Regression of a primary gastric MALT lymphoma with extensive antrum lesions by Helicobacter pylori eradication. |
1997 |
Ital J Gastroenterol Hepatol |
pmid:9476192
|